Connect Capital and Science to Shape the Future
As part of the 25th Annual Bio-IT World Conference & Expo, the 3rd Annual Bio-IT World Venture, Innovation & Partnering Conference (May 19, 2026) delivers an executive-level platform for investors, corporate leaders, and entrepreneurs driving the next wave of biotech and precision medicine. This boutique event convenes C-suite leaders from venture capital, private equity, corporate venture arms, growth-stage companies, and pharma. The 2026 program zeroes in on AI-driven discovery, platform vs. product investment models, evolving M&A and partnership strategies, IPO and private liquidity pathways, and regulatory shifts shaping capital deployment. Sessions are designed to provide investors with clear insights into market dynamics, risk-adjusted returns, and scalable innovation strategies. Through candid discussions, fireside chats, and curated panels, participants will explore how capital is being allocated, where innovation pipelines are headed, and how to identify long-term winners. Alongside investor-focused dialogue, attendees gain access to 150+ exhibits, 11 scientific tracks, and global partners from 30+ countries to broaden market perspective.
Meet Our 2026 Co-Chairs
William (Bill) Mayo
Senior Vice President, Research Technology
BMS
Morgan Cheatham, MD
Partner, Head of Healthcare & Life Sciences
Breyer Capital
Rana Lonnen
General Partner
Science Capital
Below is a partial list of perennial players at this year’s event
Who Should Attend
INVESTMENT FIRMS:
START-UPS and GROWTH COMPANIES:
CORPORATIONS:
Key Contacts
CONFERENCE CONTENT
Eileen Murphy, Med
Conference Producer
781-738-0049
emurphy@healthtech.com
PARTNERING & SPONSORSHIP
Brian Caine
Manager, Strategic Partnerships
908-809-0946
bcaine@healthtech.com